Gilead Sciences
GILD
$109.98
Share price
-1.15%
Change (1 day)
69.04%
Change (1 year)
Categories
Market capitalization of Gilead Sciences (GILD)
Market cap: $136.80 Billion USD
As of June 2025 Gilead Sciences has a market cap of $136.80 Billion USD. This makes Gilead Sciences the world's 125th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Gilead Sciences from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | $136.80 B | 16.64% |
| 2024 | $117.28 B | 16.19% |
| 2023 | $100.94 B | -6.25% |
| 2022 | $107.67 B | 18.26% |
| 2021 | $91.05 B | 24.68% |
| 2020 | $73.03 B | -11.22% |
| 2019 | $82.26 B | 2.59% |
| 2018 | $80.18 B | -14.31% |
| 2017 | $93.58 B | -0.81% |
| 2016 | $94.34 B | -34.43% |
| 2015 | $143.89 B | 1.84% |
| 2014 | $141.29 B | 22.62% |
| 2013 | $115.23 B | 106.55% |
| 2012 | $55.79 B | 81.47% |
| 2011 | $30.74 B | 5.78% |
| 2010 | $29.06 B | -25.35% |
| 2009 | $38.93 B | -16.39% |
| 2008 | $46.56 B | 8.95% |
| 2007 | $42.73 B | 42.74% |
| 2006 | $29.94 B | 23.89% |
| 2005 | $24.16 B | 53.89% |
| 2004 | $15.70 B | 26.36% |
| 2003 | $12.42 B | 84.99% |
| 2002 | $6.71 B | 5.91% |
| 2001 | $6.34 B | 62.22% |
| 2000 | $3.91 B | 63.84% |
| 1999 | $2.38 B | 89.26% |
| 1998 | $1.26 B | 9.73% |
| 1997 | $1.14 B | 59.86% |
| 1996 | $0.71 B |
End of Day market cap according to different sources
On Jun 14th, 2025 the market cap of Gilead Sciences was reported to be:
$136.80 Billion USD
$136.80 Billion USD
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $158.74 B | 16.03% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $116.95 B | -14.51% | 🇺🇸 USA |
 AbbVie ABBV | $337.52 B | 146.71% | 🇺🇸 USA |
 Illumina ILMN | $13.76 B | -89.94% | 🇺🇸 USA |
 Biogen BIIB | $19.14 B | -86.01% | 🇺🇸 USA |
 Pfizer PFE | $139.51 B | 1.98% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $377.99 B | 176.30% | 🇺🇸 USA |
 Eli Lilly LLY | $735.56 B | 437.67% | 🇺🇸 USA |
 Merck MRK | $205.17 B | 49.97% | 🇺🇸 USA |